Wolters Kluwer Webinar Brings Together Nursing Leaders to Discuss New Technologies

Webinar will examine the influence of ChatGPT, generative AI and more on nursing education

Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront. To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health, will host an online event titled, “Achieving academic excellence in nursing with new technologies: An Ovid® Synthesis webinar,” on Tuesday, June 13th from 2 to 3pm ET.

“In the midst of rapid adoption of AI-based technologies globally, a range of concerns ranging from academic integrity to plagiarism to misinformation has heightened the awareness among educators surrounding a need for action,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice at Wolters Kluwer Health. “The academic landscape must examine the best ways to benefit from these technologies while understanding the risks that may come with the implementation.”

The issues facing faculty and nursing students when it comes to using new technologies can seem overwhelming, so it is especially important to understand how generative AI could be used in developing research, EBP, and QI projects. In addition to the conversation around AI, the expert group will highlight how Ovid Synthesis can support a learning environment that promotes independent critical thinking and academic integrity.

The distinguished group of panelists that will discuss the oversight, guidance and support needed for academia facing this inflection point, includes:

  • Marilyn H. Oermann, PhD, RN, ANEF, FAAN, Thelma M. Ingles Professor of Nursing, Duke University School of Nursing; Editor-in-Chief, Nurse Educator
  • Grace H. Sun, MSN, NP, Associate Professor, Texas Tech University Health Sciences Center
  • Stephanie H. Hoelscher, DNP, RN-BC, CPHIMS, CHISP, FHIMSS, Associate Professor of Graduate Informatics and an Informatics Nurse Specialist, Texas Tech University Health Sciences Center
  • Shea Polancich, PhD, RN, Associate Professor and Assistant Dean, University of Alabama at Birmingham School of Nursing
  • (Host) Rachel Dicker, Product Management Associate Director, Wolters Kluwer, Health Learning, Research & Practice

Working in tandem with other groundbreaking technologies, Ovid Synthesis serves as a research repository, allowing all project information to be organized and stored in one simple solution, eliminating breakdowns and stalled projects. Learn more about how Ovid Synthesis can support your organization’s academic research challenges.

Wolters Kluwer Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.